Condition: Upper Urinary Tract Urothelial Carcinoma · Urothelial Carcinoma · Sponsor: UroGen Pharma Ltd.
This study will evaluate the efficacy and safety of UGN-104, a new formulation of UGN-101 (approved in the United States and Israel as JELMYTO \[mitomycin\] for pyelocalyceal solution), instilled in the upper urinary tract (UUT) of patients with low-grade upper tract urothelial cancer (LG-UTUC).
This description comes directly from the study's public registry record.
Renee Sumlin · 346-573-2671 · renee.sumlin@urogen.com
Yafit Makmal · yafit.makmal@urogen.com
Always discuss trial participation with your own doctor first.
| Urology Centers of Alabama | Homewood, Alabama, United States | Recruiting |
| Arizona State Urological Research Institute, LLC ("ASURI") | Chandler, Arizona, United States | Recruiting |
| East Valley Urology Center of Arizona | Queen Creek, Arizona, United States | Recruiting |
| University of Arkansas for Medical Sciences | Arkansas City, Arkansas, United States | Recruiting |
| Michael G Oefelein Clinical Trials | Bakersfield, California, United States | Recruiting |
| UC Irvine Health. Chao Family Comprehensive Cancer Center | Orange, California, United States | Recruiting |
| Bioresearch Partner - Aventura | Aventura, Florida, United States | Recruiting |
| University of Florida Health (UF Health), Cancer Center | Gainesville, Florida, United States | Recruiting |
| Bioresearch Partner - Hialeah Hospital | Hialeah, Florida, United States | Recruiting |
| D&H National Research Centers - Cancer Research Center, LLC | Margate, Florida, United States | Recruiting |
| Urology Center of Iowa Research | Clive, Iowa, United States | Recruiting |
| The Urology Center, P.C. | Omaha, Nebraska, United States | Completed |
+ 50 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06774131